Prevalence and Nature of Hearing Loss in 22q11.2 Deletion Syndrome by Van Eynde, Charlotte et al.
Downloa
Terms oJSLHRResearch ArticleaOtorhinolary
Leuven, Belgi
bCenter for H
cExpORL, KU
Corresponden
Editor: Nancy
Associate Edi
Received Mar
Revision rece
Accepted Nov
DOI: 10.1044
ded From: htt
f Use: http://puPrevalence and Nature of Hearing Loss in
22q11.2 Deletion SyndromeCharlotte Van Eynde,a Ann Swillen,b Elien Lambeens,a Nicolas Verhaert,a,c
Christian Desloovere,a Heleen Luts,c Vincent Vander Poorten,a
Koenraad Devriendt,b and Greet Hensa,cPurpose: The purpose of this study was to clarify the
prevalence, type, severity, and age-dependency of hearing
loss in 22q11.2 deletion syndrome.
Method: Extensive audiological measurements were
conducted in 40 persons with proven 22q11.2 deletion
(aged 6–36 years). Besides air and bone conduction thresholds
in the frequency range between 0.125 and 8.000 kHz, high-
frequency thresholds up to 16.000 kHz were determined
and tympanometry, acoustic reflex (AR) measurement, and
distortion product otoacoustic emission (DPOAE) testing
were performed.
Results: Hearing loss was identified in 59% of the tested
ears and was mainly conductive in nature. In addition, angology, Head and Neck Surgery, University Hospitals
um
uman Genetics, University Hospitals Leuven, Belgium
Leuven, Belgium
ce to Greet Hens: greet.hens@uzleuven.be
Tye-Murray
tor: Suzanne Purdy
ch 22, 2015
ived July 28, 2015
ember 18, 2015
/2015_JSLHR-H-15-0098
Journal of Speech, Language, and Hearing Research • 1–7 • Copyr
p://jslhr.pubs.asha.org/ by a KU Leuven - Biomedical Library U
bs.asha.org/ss/rights_and_permissions.aspxhigh-frequency sensorineural hearing loss with down-sloping
curve was found in the majority of patients. Aberrant
tympanometric results were recorded in 39% of the ears.
In 85% of ears with a Type A or C tympanometric peak,
ARs were absent. A DPOAE response in at least 6 frequencies
was present in only 23% of the ears with a hearing threshold
≤30 dB HL. In patients above 14 years of age, there was a
significantly lower percentage of measurable DPOAEs.
Conclusion: Hearing loss in 22q11.2 deletion syndrome is
highly prevalent and both conductive and high-frequency
sensorineural in nature. The age-dependent absence of
DPOAEs in 22q11.2 deletion syndrome suggests cochlear
damage underlying the high-frequency hearing loss.The22q11.2 deletion syndrome (22q11DS), also knownas Shprintzen syndrome, velocardiofacial syndrome,or Di George syndrome, is one of the most com-
mon chromosomal microdeletion syndromes with an esti-
mated incidence of one in every 4,000 births (Devriendt,
Fryns, Mortier, van Thienen, & Keymolen, 1998). It results
from a hemizygous deletion at the 22q11.2 locus of usually
3 megabases (MB) in size, though atypical shorter deletions
are present in about 15% of patients. The typical 3 MB
deleted region encompasses about 45 different genes, of
which mainly the TBX1 gene has been linked to the pheno-
typical features of 22q11DS (Kobrynski & Sullivan, 2007).
22q11DS has an autosomal dominant inheritance, but most
cases (>90%) result from de novo events, with both parents
unaffected (McDonald-McGinn & Zackai, 2008). Since
1992, submicroscopic 22q11.2 deletions can be diagnosedby fluorescent in situ hybridization (FISH). More recent
techniques, such as genome-wide microarray-based tests
and multiplex ligation-dependent probe amplification, also
allow detection of atypical 22q11.2 deletions that do not
include the target sequences of the common FISH probes
(Bassett et al., 2011), and are gradually replacing diagnosis
by FISH.
Phenotypically, 22q11DS is associated with a large
range of anomalies in different organ systems, but symptoms
vary widely across patients. The most frequent clinical
manifestations are developmental and/or learning difficulties,
behavioral issues, congenital conotruncal cardiac anomalies,
immunodeficiency, a (submucous) cleft palate, velophar-
yngeal insufficiency, a characteristic facial appearance,
psychiatric illness, and hypocalcaemia (Kobrynski & Sullivan,
2007; Vantrappen et al., 1999).
Hearing loss is a common feature in patients with
22q11DS, with a reported prevalence of 40%–65% (Digilio
et al., 1999; Persson, Friman, Óskarsdóttir, & Jönsson,
2012; Reyes, LeBlanc, & Bassila, 1999; Zarchi et al., 2011).
In particular, during childhood, patients with 22q11DS
are known to have a high prevalence of middle ear effusion
and recurrent acute middle ear infections, resulting in con-
ductive hearing loss (Digilio et al., 1999; Reyes et al., 1999).
Dysfunction of the Eustachian tube due to the abnormalDisclosure: The authors have declared that no competing interests existed at the time
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frequent middle ear problems, which is supported by recent
work in mouse models of 22q11DS (Df1/+ and Tbx1+/−),
showing a correlation between the presence of otitis media
with effusion and hypoplastic levator veli palatini muscles
(Fuchs, Linden, Baldini, & Tucker, 2015; Fuchs et al., 2013).
Another factor that may increase the likelihood of middle
ear problems in 22q11DS is the associated immunodefi-
ciency. Although this is classically described as cell-mediated
(thymus hypoplasia and resulting deficits in T-cell numbers),
alterations in the humoral compartment (deficiencies of
IgA, IgM, IgG, or specific antibodies) have been reported
in these patients, which seem to be significantly correlated
with recurrent (middle ear) infections (Finocchi et al., 2006;
McLean-Tooke, Spickett, & Gennery, 2007). Besides con-
ductive hearing loss, sensorineural hearing loss is also
reported in 22q11DS, though data on its prevalence vary
widely, ranging from 7% to 47% of patients in different
studies (Digilio et al., 1999; Dyce et al., 2002; Persson
et al., 2012; Reyes et al., 1999; Zarchi et al., 2011). Zarchi
et al. (2011) found the sensorineural hearing loss to be
most pronounced in the high frequencies up to 8 kHz and
positively correlated with age.
Speech and language difficulties are among the most
distressing problems that children with 22q11DS and their
parents face (Lima, Folling, Eiklid, Natvig, & Abrahamsen,
2010). They are caused by different factors. The onset and
development of language is often delayed (Solot et al., 2001).
Palatal abnormalities and velopharyngeal insufficiency
may hamper intelligibility, even after corrective surgery
(Spruijt, ReijmanHinze, Hens, Vander Poorten, & Mink
van der Molen, 2012). Voice problems, with or without
structural laryngeal anomaly, may also contribute to the
problems with speech and language (Leopold et al., 2012).
Last, hearing loss is associated with an increased prevalence
of speech delay in children with 22q11DS and has a dele-
terious impact on intelligibility into adulthood (Digilio
et al., 1999; Persson et al., 2012; Reyes et al., 1999). Though
the relative contribution of hearing loss on speech and lan-
guage difficulties in 22q11DS needs to be further studied,
an optimal management of hearing loss is without doubt
important in these patients who have a multifactorial vul-
nerability for speech and language difficulties. To explore
the prevalence, the severity, the type, and the prognosis
of hearing loss in 22q11DS, we performed extensive audio-
logical tests in patients with 22q11DS of different ages.Materials and Methods
Participants
Eighty-two participants with 22q11DS with a mini-
mum age of 6 years were identified using the database
of the Centre of Human Genetics and ENT Department,
University Hospitals Leuven and were invited to participate
in the study, of which 40 agreed to undergo extensive audio-
logical testing. The age of the participants ranged between
6 and 36 years (mean age 15 years) and the male/female2 Journal of Speech, Language, and Hearing Research • 1–7
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committee of the hospital. All participants or their parents
gave written informed consent.
Procedure
From all patients or their parents, a detailed otological
history was obtained and otomicroscopy was performed
by an otorhinolaryngologist to identify outer or middle ear
problems. The audiologic protocol included the following
measurements: standard pure-tone audiometry (frequency
range from 0.125 to 8.000 kHz), high-frequency audiometry
(frequency range 8 to 16 kHz), 226 Hz tympanometry,
acoustic reflex (AR) testing and otoacoustic emissions
(DPOAE) measurement. All tests were carried out by an
experienced audiologist in our tertiary medical center.
The thresholds of an individual’s hearing sensitivity
for calibrated pure tones were measured using standard
pure-tone audiometry (0.125–8.000 kHz) and high-frequency
audiometry (8–16 kHz). The measurements were conducted
in a sound-attenuated room with a Madsen Astera or a
Madsen Orbiter 922 v.2 audiometer (Otometrics, Taastrup,
Denmark), both similarly calibrated. Both air conduction
(AC) and bone conduction (BC) thresholds were determined
to discriminate between conductive and sensorineural hear-
ing loss. AC thresholds were measured at the frequencies
0.125, 0.250, 0.500, 1.000, 2.000, 4.000, 8.000, 9.000, 10.000,
11.200, 12.500, 14.000, and 16.000 kHz. BC thresholds
were measured at the frequencies 0.25, 0.50, 1.00, 2.00, and
4.00 kHz. All thresholds are reported in dB HL. Masking
was applied when necessary.
On the basis of these measurements, three pure-tone
averages (PTAs) were calculated for each ear, representing
the hearing thresholds at different frequency ranges: the
standard PTA (PTA, the average of the thresholds at 0.5,
1.0, and 2.0 kHz), the high-frequency PTA (HF PTA, the
average of the thresholds at 4 and 8 kHz), and the extended
high-frequency PTA (EHF PTA, the average of the thresh-
olds at 9.0, 10.0, and 11.2 kHz).
We made a first classification of the type of hearing
loss on the basis of the standard PTA in AC and BC. The
hearing was classified as normal when the AC PTA was
≤15 dB (Clark, 1981). An AC PTA above 15 dB was clas-
sified as a hearing loss. The hearing loss was considered to
be conductive if the BC PTA was ≤15 dB and the air–bone
gap (ABG) was ≥10 dB, sensorineural if the BC PTA was
>15 dB and the ABG was <10 dB, and mixed if the BC
PTA was >15 dB and the ABG was ≥10 dB. The severity
of the hearing loss was classified according to Clark
(1981): slight hearing loss (16–25 dB HL), mild hearing
loss (26–40 dB HL), moderate hearing loss (41–55 dB HL),
moderate-severe hearing loss (56–71 dB HL), and severe
hearing loss (>71 dB HL).
Tympanometry and AR testing were performed
using a Madsen Zodiac 901. Tympanometry measures the
compliance of the tympanic membrane, providing informa-
tion on tympanic membrane and middle ear functioning.
The resulting tympanogram was classified as Type A, which isser  on 06/07/2016
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which represents a negative middle ear pressure (pressure
peak less than −105 daPa), or Type B (a flat curve, no mea-
surable peak), representing a lack of mobility of the tym-
panic membrane (in case of middle ear effusion or tympanic
membrane perforation; Alaerts, Luts, & Wouters, 2007).
ARs were measured when the tympanometric response
showed a Type A or a Type C curve. The AR is a contrac-
tion of the stapedius and tensor tympani muscle in the mid-
dle ear as a response to high-intensity sound stimuli. It is
a protective reflex, creating a stiffness of the ossicular chain
and therefore reducing the sound transmission to the co-
chlea. Ipsilateral measurements were conducted at the fre-
quencies 0.5, 1.0, and 2.0 kHz. Absence of the AR was
defined as a failure to elicit the response at the maximum
stimulation intensity of 105 dB SPL.
DPOAEs were measured with the Otodynamics ILOv6
software (Otodynamics, Hatfield, United Kingdom). Sound
is transmitted through a probe placed in the ear canal. At
the same time the acoustic response generated by the outer
hair cells is measured. The presence of measurable DPOAEs
indicates a normal outer hair cell function in the cochlea.
A DPOAE response was measured in the seven frequency
bands—1.0, 1.4, 2.0, 2.8, 4.0, 6.0, and 8.0 kHz—and was
expressed in dB SPL. The DPOAEs were considered normal
when the signal-to-noise ratio (SNR) was ≥6 dB in six or
seven of the frequency bands. When a SNR ≥6 dB was
reached in three to five frequency bands, the DPOAE re-
sponse was regarded as weak. When a SNR ≥6 dB was
found in fewer than three frequency bands, the DPOAEs
were considered absent. To rule out outer and middle ear
problems as causes of absent DPOEAs, DPOAEs were not
measured in cases of otitis media with effusion, outer ear
canal stenosis, presence of ventilation tubes, and tympanic
membrane perforation, because these outer and middle ear
problems weaken the signal that’s being sent to and reflected
by the cochlea, even when there is no outer hair cell dam-
age. In outer hair cell pathology, only the reflected signal will
be reduced or absent. For the same reason, only ears with
a PTA better than 30 dB HL were included.
Statistical Analysis
To compare percentages of normal versus abnormal
otomicroscopies, tympanometries, ARs, and otoacoustic
emissions in different age categories, we used the chi square
(χ2) test or the Fisher Exact test as appropriate. Correlations
between age and hearing thresholds were analyzed using
the Pearson correlation coefficient after normality checking.
The significance level was set on p < .05.
Results
Otomicroscopic Examination
Otomicroscopy was performed in all participants. In
55% of ears, the outer ear and tympanic membrane were
normal. Observed abnormalities included otitis media with
effusion, tympanic membrane retraction, myringosclerosis,ded From: http://jslhr.pubs.asha.org/ by a KU Leuven - Biomedical Library U
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tion tubes, and tympanic membrane perforation. An over-
view is given in Table 1. There were significantly more
abnormal otomicroscopic findings in the age group below
15 years of age (p < .001, χ2test).
Pure-Tone Audiometry
On the basis of the standard PTA, 78% of the partic-
ipants presented with a unilateral (38%) or bilateral (40%)
hearing loss. Interpreting these results per ear, we found a
hearing loss in 59% of ears. The hearing loss was conductive
in 53%, sensorineural in 4%, and mixed in 2% of ears.
Figure 1 shows the mean AC and BC thresholds on the ba-
sis of the standard pure tone audiometry (0.125–8.000 kHz).
The average standard audiogram in 22q11DS presents a
mild conductive hearing loss with an ABG of 20–30 dB. In
Figure 2, mean AC thresholds for the high-frequency range
(8–16 kHz) are shown. The average high-frequency audio-
gram in 22q11DS has a down-sloping curve, representing
a high-frequency sensorineural component to the hearing
loss.
In individuals with 22q11DS, hearing loss is both more
prevalent and more severe in the high frequencies. Indeed,
although 59% of ears present with a hearing loss on the
basis of the PTA, this increases to 65% on the basis of the
HF PTA, and further to 79% on the basis of the EHF
PTA. And although the majority of patients presents with
a slight or mild hearing loss in the standard PTA (mean
20 ± 12 dB HL), the hearing loss is on average more
severe in the higher frequencies, with a mean HF PTA
of 23 ± 14 dB HL and a mean EHF PTA of 34 ± 22 dB HL.
The distribution of tested ears according to the grade of
severity of hearing loss in the three frequency ranges is
presented in Figure 3. No significant age correlation was
found for the PTA (Pearson r −.01), the HF PTA (Pearson
r .039), nor the EHF PTA (Pearson r .211).
Tympanometry and Acoustic Reflex Measurement
A tympanometry was conducted in 66 of the 80 ears
(83%). Fourteen ears could not be tested because of the
presence of a perforation in the tympanic membrane, ven-
tilation tubes, external otitis, auditory canal stenosis, or
test rejection. Of the tested patients, 61% presented with a
Type A tympanogram, 12% a Type B tympanogram, and
27% a Type C tympanogram. In 30% of ears exhibiting
a conductive or mixed hearing loss, a Type A curve was
nevertheless found on tympanometry. The difference of
normal versus abnormal tympanometric responses in dif-
ferent age categories (6–14 years vs. 15–36 years) was not
significant (χ2 test p = .37).
An ipsilateral AR measurement was conducted in
all ears with a Type A or Type C curve on tympanometry
(n = 55). In 33% of these ears, we found a response on
at least one frequency. The difference in the percentage
of absent ARs in different age categories (6–14 years vs.
15–36 years) was not significant (χ2 test p = .74).Van Eynde et al.: Hearing Loss in 22q11.2 Deletion Syndrome 3
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Table 1. Otomicroscopic findings.
Finding
All ears
(n = 80), No. (%)
Ears of patients
<15 years of age
(n = 42), No. (%)
Ears of patients
≥15 years of age
(n = 38), No. (%)
Normal 44 (55) 16 (38) 28 (74)
Otitis media with effusion 3 (4) 2 (5) 1 (3)
Tympanic membrane retraction 4 (5) 1 (2) 3 (7)
Myringosclerosis 14 (18) 10 (24) 4 (10)
Auditory canal stenosis 1 (1) 0 (0) 1 (3)
External otitis 2 (2) 2 (5) 0 (0)
Ventilation tubes in situ 5 (6) 4 (10) 1 (3)
Tympanic membrane perforation 7 (9) 7 (17) 0 (0)
Downloa
Terms oDPOEA Measurement
Forty-four ears could be included for the measurement
of DPOEAs (see Methodology). Within this group there was
a high degree of absent or weak responses (77%). Only 9%
of the ears showed a response at all seven frequencies. There
was a significantly higher degree of absence in the age cate-
gory 15–36 years (83%), compared to the younger patients
(29%; Fisher’s exact test p < .001; see Figure 4).Figure 2. Mean AC thresholds in the frequency range 8–16 kHz inDiscussion
We found a hearing loss in at least one ear in 78%
of participants with 22q11DS, on the basis of a standard
PTA >15 dB HL. Bilateral hearing loss was found in 40%
of patients. The prevalence of hearing loss in this study
seems to exceed earlier reported prevalences of 40%–65%
(Digilio et al., 1999; Persson et al., 2012; Reyes et al., 1999;
Zarchi et al., 2011). There is, however, no uniformity in
the criteria to define a hearing loss. Although most authors
used the average of thresholds at 500, 1000, and 2000 Hz
to calculate PTA, Reyes et al. (1999) also included the
4000 Hz frequency, and Zarchi et al. (2011) failed to reportFigure 1. Mean AC and BC thresholds in the frequency range
0.125–8.000 kHz in 22q11DS (n = 80 ears, age 6–36 years).
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standard PTA of >15 dB HL as a hearing loss in accor-
dance with the classification of Clark (1981), whereas most
authors used a threshold of >20 dB HL (Digilio et al., 1999;
Persson et al., 2012; Reyes et al., 1999) or even >25 dB HL
(Zarchi et al., 2011) to define hearing impairment. Reanalyz-
ing our data, we find a prevalence of hearing loss (in at least
one ear) of 60% using the criterion of >20 dB HL, which
is in accordance with the previously reported data. The
prevalence of hearing loss in persons with 22q11DS greatly
exceeds the general prevalence of hearing loss found in large
population-based surveys. For example, a PTA >15 dB HL
is reported in about 15% of children between 6–19 years
of age (Niskar et al., 1998), and 3%–5% of adults aged
20–40 years have a PTA ≥25 dB HL (Agrawal, Platz, &
Niparko, 2008).
Two components contribute to the hearing loss in
22q11DS. In the lower frequencies (standard PTA), we found
a hearing loss in 59% of ears, which is mostly conductive
in nature and of slight to mild severity (see Figure 1 and22q11DS (n = 76 ears, age 6–36 years).
ser  on 06/07/2016
Figure 3. Distribution of tested ears according to the grade of
severity of hearing loss for each of the three frequency ranges:
PTA, HF PTA, and EHF PTA.
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majority of participants presented with a high-frequency
hearing loss, which can be assumed to be of sensorineural
origin. Our study is the first to report on hearing thresh-
olds in frequencies above 8 kHz in 22q11DS, clearly dem-
onstrating a down-sloping curve in this frequency range
on the audiogram (see Figure 2). Considering the EHF
PTA (9.0, 10.0, and 11.2 kHz), we found a hearing loss in
79% of ears, which was mostly mild to moderate in severity
(see Figure 3).
The conductive component of the hearing loss in
22q11DS is usually attributed to Eustachian tube dysfunction,
otitis media with effusion, and recurrent middle ear infections
in the pediatric 22q11DS population. In analogy with the
cleft palate population, one would expect that Eustachian
tube dysfunction caused by malfunctioning of the velar
musculature would improve with age (Timmermans, VanderFigure 4. Percentages of present, weak, and absent DPOAEs in
patients with 22q11DS of different age groups.
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though our study showed a significantly lower percentage
of normal otomicroscopy findings in the age group from
6 to 14 years old versus the older participants (15–36 years
old), the percentage of abnormal tympanometric results
and the percentage of conductive hearing losses did not
differ between the two groups. Moreover, the conductive
hearing loss cannot fully be explained by Eustachian tube
dysfunction, because 30% of ears with a conductive hearing
loss demonstrated a Type A curve on tympanometry.
On the other hand, congenital middle ear anomalies may
explain part of the conductive losses seen in 22q11DS.
Three cases of congenital ossicular chain anomalies are
described in patients with 22q11DS (Cunningham et al.,
2003; Devriendt, Swillen, Schatteman, Lemmerling, &
Dhooge, 2004), and murine studies show a crucial role of
Tbx1 in the development of both middle and inner ear
(Arnold et al., 2006). No large series of CT-scans of the
petrosal bones in patients with 22q11DS are available,
partly because of ethical considerations, and it is therefore
currently not possible to estimate the true incidence of con-
genital middle ear malformations in 22q11DS. Another
factor in the persistence of conductive hearing loss into
adulthood in patients with 22q11DS, may be the develop-
ment of tympanosclerotic middle ear changes due to
chronic and acute otitis media in childhood. These sclerotic
middle ear changes may also account for the high preva-
lence of absent ARs in 22q11DS as found by Zarchi et al.
(2011) and as confirmed in our research. Other causes
for malfunctioning of the ARs in 22q11DS may be con-
genital stapedial anomalies and the general muscular
hypotonia found in these patients.
DPOEAs were absent in 57% of the ears with a PTA
<30 dB HL in our study population, indicating malfunc-
tioning of the outer hair cells and thus suggesting a cochlear
origin of the high-tone sensorineural hearing loss. Several
possible mechanisms may contribute to this hearing loss.
Besides middle ear malformations, congenital inner ear
anomalies have been described in 22q11DS, such as a
Mondini-type cochlear malformation (Devriendt et al.,
2004) or a common cavity between the vestibule and the
lateral semicircular canal (Devriendt et al., 2004; Hopsu,
Markkola, & Pitkäranta, 2007), which may be caused by
the Tbx1 hemizygosity (Arnold et al., 2006). On the other
hand, middle ear inflammation can cause ototoxic damage
via diffusion of inflammatory mediators through the round
window membrane, affecting the hair cells in the basal
cochlear duct and thus the high-frequency hearing thresh-
olds (Joglekar et al., 2010; Margolis, Saly, & Hunter, 2000).
In addition, Zarchi et al. (2011) postulated that the sen-
sorineural hearing loss in 22q11DS may be noise-induced
secondary to dysfunction of the protective ARs, but the
relatively well-preserved hearing at the frequency of 4000 Hz
makes this unlikely. Not one of the participants in our study
presented with a typical noise-induced 4000-Hz threshold
dip on their audiogram. In their study, there was a positive
correlation between the severity of the high-frequency hear-
ing loss and age, which was not significant in our studyVan Eynde et al.: Hearing Loss in 22q11.2 Deletion Syndrome 5
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were more frequently absent in older patients, favoring the
hypothesis of cochlear damage due to middle ear effusion and
infections. Congenital cochlear anomalies or immunological
deficits in 22q11DS may cause the cochlea to be more vul-
nerable to permanent damage, resembling the cochlear fra-
gility described in Williams syndrome (Barozzi et al., 2013).
Longitudinal studies on hearing in 22q11DS, including
DPOEA testing and high-frequency audiometry, would be
informative in future.
In conclusion, hearing loss is highly prevalent in
22q11DS, and both conductive and high-tone sensorineural
in nature. The decreased presence of DPOEAs in ears of
older participants with 22q11DS suggests cochlear damage
as the plausible mechanism for the development of the
high-frequency hearing loss. Rigorous otological follow-up
and prompt treatment of middle ear infections and effusion
is advisable in this population at high risk for speech and
language difficulties.Acknowledgment
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